"Precision" Medicine in Membranous Nephropathy: Serology-Guided Therapy.
作者信息
Glassock Richard J, Fervenza Fernando C
机构信息
Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
出版信息
Kidney Int Rep. 2023 Jan 28;8(3):397-400. doi: 10.1016/j.ekir.2023.01.024. eCollection 2023 Mar.
Abstract
摘要
相似文献
1
"Precision" Medicine in Membranous Nephropathy: Serology-Guided Therapy.
Kidney Int Rep. 2023 Jan 28;8(3):397-400. doi: 10.1016/j.ekir.2023.01.024. eCollection 2023 Mar.
2
Membranous nephropathy: current understanding of various causes in light of new target antigens.
Curr Opin Nephrol Hypertens. 2021 May 1;30(3):287-293. doi: 10.1097/MNH.0000000000000697.
3
Pharmacological treatment of primary membranous nephropathy in 2016.
Expert Rev Clin Pharmacol. 2016 Nov;9(11):1463-1478. doi: 10.1080/17512433.2016.1225497. Epub 2016 Sep 16.
4
Noninvasive Diagnosis of PLA2R-Associated Membranous Nephropathy: A Validation Study.
Clin J Am Soc Nephrol. 2021 Dec;16(12):1833-1839. doi: 10.2215/CJN.05480421. Epub 2021 Nov 15.
5
Rituximab Treatment in a Patient with Kimura Disease and Membranous Nephropathy: Case Report.
Case Rep Nephrol Dial. 2021 Jun 14;11(2):116-123. doi: 10.1159/000515644. eCollection 2021 May-Aug.
6
How Does Herbal Medicine Treat Idiopathic Membranous Nephropathy?
Front Pharmacol. 2020 Jul 3;11:994. doi: 10.3389/fphar.2020.00994. eCollection 2020.
7
Prevalence and immunopathologic characteristics of seropositive and seronegative hepatitis B virus-associated membranous nephropathy: a retrospective study of 420 biopsy-proven cases.
Ren Fail. 2024 Dec;46(1):2313180. doi: 10.1080/0886022X.2024.2313180. Epub 2024 Feb 12.
8
Membranous Nephropathy: Updates on Management.
Adv Kidney Dis Health. 2024 Jul;31(4):299-308. doi: 10.1053/j.akdh.2024.04.004.
9
Primary Membranous Nephropathy With Enhanced Staining of Exostosin 1/Exostosin 2 in the Glomeruli: A Report of 2 Cases.
Kidney Med. 2021 May 31;3(4):669-673. doi: 10.1016/j.xkme.2021.03.013. eCollection 2021 Jul-Aug.
10
Biomarkers in Primary Membranous Nephropathy, A Guide to Precision Medicine.
Iran J Kidney Dis. 2020 Sep;14(5):335-347.
引用本文的文献
1
Ten tips on immunosuppression in primary membranous nephropathy.
Clin Kidney J. 2024 Apr 29;17(6):sfae129. doi: 10.1093/ckj/sfae129. eCollection 2024 Jun.
2
How to Choose the Right Treatment for Membranous Nephropathy.
Medicina (Kaunas). 2023 Nov 14;59(11):1997. doi: 10.3390/medicina59111997.
本文引用的文献
1
Antibody-Guided Therapy in Phospholipase A2 Receptor-Associated Membranous Nephropathy.
Kidney Int Rep. 2022 Dec 13;8(3):432-441. doi: 10.1016/j.ekir.2022.12.003. eCollection 2023 Mar.
2
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases.
Kidney Int. 2021 Oct;100(4S):S1-S276. doi: 10.1016/j.kint.2021.05.021.
3
Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy.
Front Immunol. 2021 Mar 22;12:593288. doi: 10.3389/fimmu.2021.593288. eCollection 2021.
4
New 'Antigens' in Membranous Nephropathy.
J Am Soc Nephrol. 2021 Feb;32(2):268-278. doi: 10.1681/ASN.2020071082. Epub 2020 Dec 30.
5
Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era.
Pediatr Nephrol. 2021 Jan;36(1):19-30. doi: 10.1007/s00467-019-04425-1. Epub 2019 Dec 6.
6
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
N Engl J Med. 2019 Jul 4;381(1):36-46. doi: 10.1056/NEJMoa1814427.
7
Comparison of 2 Anti-PLA2R Immunoassays for the Diagnosis of Primary Membranous Nephropathy.
Lab Med. 2018 Oct 11;49(4):316-322. doi: 10.1093/labmed/lmy016.
8
A Proposal for a Serology-Based Approach to Membranous Nephropathy.
J Am Soc Nephrol. 2017 Feb;28(2):421-430. doi: 10.1681/ASN.2016070776. Epub 2016 Oct 24.
9
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.
N Engl J Med. 2009 Jul 2;361(1):11-21. doi: 10.1056/NEJMoa0810457.
Zotero 插件